Trial Profile

A Global Phase III Trial of SB-030 to Prevent Vein Graft Failure in Peripheral Artery Disease

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 26 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SB 030 (Primary)
Indications Peripheral arterial disorders; Transplant rejection
Focus Registrational; Therapeutic Use
Sponsors Symic Bio

Most Recent Events

25 Apr 2019 According to a Symic Bio media release, this study is expected to start in 2020.
29 May 2017 New trial record
22 May 2017 According to a SYMIC Biomedical media release, the company anticipates initiating this trial in 2018.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com